The Present and Future of Monoclonal Antibody Therapies for Multiple Sclerosis.
Saved in:
| Title: | The Present and Future of Monoclonal Antibody Therapies for Multiple Sclerosis. |
|---|---|
| Authors: | Susin-Calle S; Department of Neurology, Hospital del Mar, Doctor Aiguader 88, 08003, Barcelona, Spain.; Department of Medicine and Life Sciences, Pompeu Fabra University, Barcelona, Spain., Munteis E; Department of Neurology, Hospital del Mar, Doctor Aiguader 88, 08003, Barcelona, Spain.; Department of Medicine and Life Sciences, Pompeu Fabra University, Barcelona, Spain., Villoslada P; Department of Neurology, Hospital del Mar, Doctor Aiguader 88, 08003, Barcelona, Spain. pvilloslada@researchmar.net.; Department of Medicine and Life Sciences, Pompeu Fabra University, Barcelona, Spain. pvilloslada@researchmar.net., Martinez-Rodriguez JE; Department of Neurology, Hospital del Mar, Doctor Aiguader 88, 08003, Barcelona, Spain.; Department of Medicine and Life Sciences, Pompeu Fabra University, Barcelona, Spain. |
| Source: | BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy [BioDrugs] 2025 Nov; Vol. 39 (6), pp. 815-826. Date of Electronic Publication: 2025 Sep 23. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9705305 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-190X (Electronic) Linking ISSN: 11738804 NLM ISO Abbreviation: BioDrugs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
